Biosimilar filgrastim treatment patterns and prevention of febrile neutropenia: a prospective multicentre study in France in patients with solid tumours (the ZOHé study)

BACKGROUND: The ZOHé study was a prospective, non-interventional, multicentre study in France to assess the use of biosimilar filgrastim Zarzio® (Sandoz filgrastim) in routine clinical practice in patients at risk of neutropenia-inducing chemotherapy (CT). METHODS: Patients ≥ 18 years undergoing CT...

Descripción completa

Detalles Bibliográficos
Autores principales: Roché, Henri, Eymard, Jean-Christophe, Radji, Abderraouf, Prevost, Alain, Diab, Rafik, Lamuraglia, Michele, Soumoudronga, Ravaka-Fatoma, Gasnereau, Isabelle, Toledano, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240200/
https://www.ncbi.nlm.nih.gov/pubmed/30445935
http://dx.doi.org/10.1186/s12885-018-4986-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240200/
https://www.ncbi.nlm.nih.gov/pubmed/30445935
http://dx.doi.org/10.1186/s12885-018-4986-1

Ejemplares similares